Skip to main content

Main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers

Secondary navigation

  • Value added services
  • CSR
  • About us

SearchSearch results for: “”

570 results

Termination Clauses and the Unacceptability Test: New Guidance from the Dutch Supreme Court

On 16 May 2025, the Dutch Supreme Court handed down a judgment (ECLI:NL:HR:2025:763) that provides further guidance on the legal doctrine concerning the termination of continuing performance contracts.

Vince Van der Wangen

Associate Brussels

EU’s GPAI Code of Practice: the world’s first guidance for General Purpose AI model compliance

The European Commission has published the Code of Practice, the worlds first stakeholder guidance on transparency, safety and security, and copyright considerations for general purpose AI-models (GPAI), which helps AI developers to comply with the AI Act.

Stibbe advises Intervest on landmark EUR 300 million logistics transaction with Weerts Logistics Parks

Stibbe advised Intervest on the acquisition of a strategic logistics real estate portfolio from Weerts Logistics Parks. Valued at approximately EUR 300 million, this landmark deal ranks among the largest ever in the Belgian logistics real estate sector.

Stibbe advises Holland Casino on sale of Zandvoort casino

Stibbe provided Holland Casino with legal advice on the sale of its Zandvoort casino.

Anna Collignon

Partner Amsterdam

The Guidelines for providers of General Purpose AI Models are here: the 10^23 FLOPS question?

The European Commission published Guidelines for GPAI model providers, helping them understand AI Act requirements for general purpose AI models before the 2 August 2025 compliance deadline.

Roos Snell

Junior Associate (awaiting bar admission) Amsterdam

Estelle Langenaeken

Junior Associate Brussels

Vijfde Didam Update

De Didam-jurisprudentie ontwikkelt zich verder: lees onze beknopte bespreking van twaalf belangrijke uitspraken van de afgelopen twee jaar

Legal Considerations for Artificial Intelligence in the Life Sciences Sector

This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.

Auke-Frank Tadema

Associate Amsterdam

Pagination

  • Previous page
  • Page 29
  • Page 30
  • Page 31
  • Current page 32
Reset filters
Date
Content type
  • Article (183)
  • Event (29)
  • Inside Stibbe (14)
  • Interview (1)
  • Matter (281)
  • Podcast (4)
  • People (58)
Expertise
  • (-) Intellectual Property (121)
  • (-) Real Estate (470)
  • Audit Firms and Accountancy (76)
  • Banking and Finance (429)
  • Capital Markets (247)
  • Compliance, Sanctions and Risk (162)
  • Corporate and M&A (864)
  • Corporate Investigations (31)
  • Criminal Law and Enforcement (143)
  • Digital Economy (108)
  • Employment, Benefits and Pensions (409)
  • Energy, Industry and Climate (311)
  • Environment and Planning (882)
  • ESG & Sustainability (295)
  • EU and Competition Law (492)
  • Financial Regulation (173)
  • Healthcare and Life Sciences (86)
  • Infrastructure and Mobility (192)
  • Insurance (36)
  • Investment Funds (141)
  • Litigation and Arbitration (426)
  • Privacy and Data Protection (204)
  • Private Equity (197)
  • Procurement Law (122)
  • Public Law (1191)
  • Restructuring and Insolvency (116)
  • Sports (25)
  • Tax (445)
  • Technology, Media and Telecommunications (331)
  • Unfair Competition and Consumer Protection (186)
Jurisdiction
  • BE Law (157)
  • EU Law (44)
  • LU Law (21)
  • NL Law (340)
Language
  • Dutch (116)
  • English (446)
  • French (8)

Footer main navigation

  • Expertise
  • Publications & Insights
  • People
  • Careers
© 2025 Stibbe

Footer navigation

  • Contact
  • Disclaimer
  • General Conditions
  • Register of legal practice areas
  • Privacy and Cookie Policy
  • Cookies Settings
  • Important Information